Original Articles (2006-2010)

  1. Funagayama M, Kazuhiro Kondo K, Chijiiwa K, Kataoka H: Expression of Hepatocyte Growth Factor Activator Inhibitor type 1 in human hepatocellular carcinoma and postoperative outcomes. World J. Surg. 34:1563-1571 (2010)
  2. Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiiwa K, Kataoka H: Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int. J. Cancer 126:1611-1620 (2010)
  3. Takami Y, Uto H, Takeshita M, Kai H, Akamatsu E, Moriuchi A, Hasegawa S, Oketani M, Ido A, Kataoka H, Tsubouchi H: Proanthocyanidin derived from the leaves of Vaccinium virgatum suppresses platelet-derived growth factor-induced proliferation of the human hepatic stellate cell line LI90. Hepatol. Res. 40:337-345 (2010)
  4. Takai H, Kato A, Ishiguro T, Kinoshita Y, Karasawa Y, Otani Y, Ogawa Y, Sugimoto M, Suzuki M, Kataoka H: Optimization of tissue processing for immunohistochemistry for the detection of human glypican-3. Acta Histochem. 112:240-250 (2010)
  5. Phin S, Sylvain Marchand-Adam S, Fabre A, Marchal-Somme J, Bantsimba-Malnda C, Kataoka H, Soler P, Crestan B: Imbalance in the pro-hgf activation system in bleomycin-induced lung fibrosis in mice. Am. J. Resp. Cell. Mol. Biol.42:286-293 (2010)
  6. Takeshita M, Ishida Y, Akamatsu E, Ohmori Y, Sudoh M, Uto H, Tsubouchi H, Kataoka H: Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C Virus RNA. J. Biol. Chem. 284:21165-76 (2009)
  7. Kawaguchi M, Orikawa H, Baba T, Fukushima T, Kataoka H: Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein. FEBS J. 276:3481-3490 (2009)
  8. Cheng H, Fukushima T, Takahashi N, Tanaka H, Kataoka H: Hepatocyte growth factor activator inhibitor type 1 regulates the epithelial to mesenchymal transition through membrane-bound serine proteinases. Cancer Res.69:1828-35 (2009)
  9. Tanaka H, Fukushima T, Yorita K, Kawaguchi M, Kataoka H: Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells. Hum. Cell, 22: 11-17 (2009)
  10. Takai H, Kato A, Kato C, Watanabe T, Matsubara K, Suzuki M, Kataoka H: The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma. Liver Int., 29:1056-64 (2009)
  11. Okura T, Marutsuka K, Hamada H, Sekimoto T, Fukushima T, Asada Y, Kitamura K, Chosa E. Therapeutic efficacy of intra-articular adrenomedullin injection in antigen-induced arthritis in rabbits. Arthritis Res. Ther.10:R133 (2008)
  12. Komaki W, Fukushima T, Tanaka H, Itoh H, Chosa E, Kataoka H: Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stress. Virchows Arch. 453: 347-357 (2008)
  13. Nagaike K, Kawaguchi M, Takeda N, Fukushima T, Sawaguchi A, Kohama K, Setoyama M, Kataoka H: Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice. Am. J. Pathol.173:1464-1475 (2008)
  14. Amano M, Kurokawa M, Ogata K, Itoh H, Kataoka H, Setoyama M.: Cutaneous type adult T-cell leukemia/lymphoma. New entity and its definition and its diagnostic criteria: HTLV-1 proviral DNA lad can distinguish between cutaneous type ATLL and smoldering type ATLL. J. Dermatol., 35:270-275 (2008)
  15. Nagai M, Takahashi N, Miyazawa K, Kawaguchi M, Chijiiwa K, and Kataoka H.: Activation of MET receptor tyrosine kinase in ulcer surface epithelial cells undergoing restitution. Pathol. Int.58:462-464 (2008).
  16. Mukai S, Fukushima T, Naka D, Tanaka H, Osada Y, Kataoka H: Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases. FEBS J., 275:1003-17 (2008)
  17. Yamasaki M, Fujita S, Ishiyama E, Mukai A, Madhyastha H, Sakakibara Y, Suiko M, Hatakeyama K, Nemoto T, Morishita K, Kataoka H, Tubouchi H, and Nishiyama K: Soy derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo. Cancer Sci., 98:1740-1746 (2007).
  18. Takajo I, Umeki K, Morishita K, Yamamoto I, Kubuki Y, Hatakeyama K, Kataoka H, and Okayama A: Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/ƒΑnull (NOG) mouse. Int. J. Cancer, 121:2205-11 (2007).
  19. Miyata S, Fukushima T, Kohama K, Tanaka H, Takeshima H, and Kataoka H: Role of Kunitz domains in anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells. Hum. Cell, 20:100-106 (2007)
  20. Fukushima T, Tezuka T, Shimomura T, Nakano S, Kataoka H: Silencing of insulin-like growth factor binding protein-2 (IGFBP-2) in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J. Biol. Chem., 282: 18634-44 (2007).
  21. Betsunoh, H., Mukai, S., Akiyama, Y., Fukushima, T., Minamiguchi, N., Hasui, Y., Osada, Y., and Kataoka, H.: The clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 (HAI-2) expression in renal cell carcinoma. Cancer Sci., 98(4):491-498 (2007).
  22. Uchiyama S, Itoh H, Naganuma S, Nagaike K, Fukushima T, Tanaka H, Hamasuna R, Chijiiwa K, Kataoka H: Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide (H2RSP) at the invasion front of colon cancers. Gut, 56: 215-226 (2007)
  23. Mori M, Ishikawa G, Luo S-S, Mishima T, Goto T, Robinson JM, Matsubara S, Takeshita T, Kataoka H, Takizawa T: The cytotrophoblast layer of human chorionic villi becomes thinner but maintains its structural integrity during gestation. Biol. Reprod., 76:164-172 (2007)
  24. Akiyama Y, Nagai M, Komaki W, Marutsuka K, Asada Y, Kataoka H: Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells. Hum. Cell, 19:91-97 (2006).
  25. Sasaki M, Ikeda H, Kataoka H, Nakanuma Y: Augumented expression of hepatocytes growth factor actuvatir inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis. Virchows Arch., 449:462-471 (2006).
  26. Uchinokura S, Miyata S, Fukushima T, Itoh H, Nakano S, Wakisaka S, Kataoka H: Role of Hepatocyte Growth Factor Activator (HGF activator) in Invasive Growth of Human Glioblastoma Cells in vivo. Int. J. Cancer, 118:583-92 (2006).
  27. Marchand-Adam, S., Fabre1, A., AndrEMailleux, A., Marchal1, J., Quesnel1, C., Kataoka, H., Aubier1, M., Dehoux, M., Soler, P., and Crestani, B.: Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Am. J. Respr. Crit. Care Med., 174:58-66 (2006).
  28. Hallikas OT, Aaltonen JA, von Koskull H, Lindberg L-A, Valmu L, Kalkkinen N, Washlstro T, Kataoka H, Andersson L, Lindholm D, Schroer J: Identification of antibodies against HAI-1 and integrin a6b4 as immunohistochemical markers of human villous cytotrophoblast. J. Histochem. Cytochem., 54:745-752 (2006).
  29. Nakanishi C, Moriuchi A, Ido A, Numata M, Kim ID, Kusumoto K, Hasuike S, Abe H, Nagata K, Akiyama Y, Uto H, Kataoka H, Tsubouchi H: Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a cholin-deficient L-amino acid-deficient diet. Oncol. Rep., 16:25-31 (2006).